BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33416118)

  • 1. MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study.
    Grossi I; Radeghieri A; Paolini L; Porrini V; Pilotto A; Padovani A; Marengoni A; Barbon A; Bellucci A; Pizzi M; Salvi A; De Petro G
    Int J Mol Med; 2021 Feb; 47(2):533-546. PubMed ID: 33416118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
    He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
    Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
    Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
    BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular beacon-based detection of circulating microRNA-containing extracellular vesicle as an α-synucleinopathy biomarker.
    Yu Z; Zheng Y; Cai H; Li S; Liu G; Kou W; Yang C; Cao S; Chen L; Liu X; Wan Z; Zhang N; Li X; Cui G; Chang Y; Huang Y; Lv H; Feng T
    Sci Adv; 2024 May; 10(20):eadl6442. PubMed ID: 38748787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.
    Sancandi M; Uysal-Onganer P; Kraev I; Mercer A; Lange S
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different miRNA Profiles in Plasma Derived Small and Large Extracellular Vesicles from Patients with Neurodegenerative Diseases.
    Sproviero D; Gagliardi S; Zucca S; Arigoni M; Giannini M; Garofalo M; Olivero M; Dell'Orco M; Pansarasa O; Bernuzzi S; Avenali M; Cotta Ramusino M; Diamanti L; Minafra B; Perini G; Zangaglia R; Costa A; Ceroni M; Perrone-Bizzozero NI; Calogero RA; Cereda C
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.
    Chung CC; Chan L; Chen JH; Hung YC; Hong CT
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy.
    Catapano F; Scaglioni D; Maresh K; Ala P; Domingos J; Selby V; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Voit T; Verschuuren JJGM; Niks EH; Straub V; Morgan J; Muntoni F
    Epigenomics; 2020 Nov; 12(21):1899-1915. PubMed ID: 33215544
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
    Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
    World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of purposeful soccer heading on circulating small extracellular vesicle concentration and cargo.
    Muñoz ER; Caccese JB; Wilson BE; Shuler KT; Santos FV; Cabán CT; Jeka JJ; Langford D; Hudson MB
    J Sport Health Sci; 2021 Mar; 10(2):122-130. PubMed ID: 33189894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis.
    Pasquali L; Svedbom A; Srivastava A; Rosén E; Lindqvist U; Ståhle M; Pivarcsi A; Sonkoly E
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1248-1256. PubMed ID: 31954077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating plasma miR-23b-3p as a biomarker target for idiopathic Parkinson's disease: comparison with small extracellular vesicle miRNA.
    Rai S; Bharti PS; Singh R; Rastogi S; Rani K; Sharma V; Gorai PK; Rani N; Verma BK; Reddy TJ; Modi GP; Inampudi KK; Pandey HC; Yadav S; Rajan R; Nikolajeff F; Kumar S
    Front Neurosci; 2023; 17():1174951. PubMed ID: 38033547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine Profile in Plasma Extracellular Vesicles of Parkinson's Disease and the Association with Cognitive Function.
    Chan L; Chung CC; Chen JH; Yu RC; Hong CT
    Cells; 2021 Mar; 10(3):. PubMed ID: 33803292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raman profiling of circulating extracellular vesicles for the stratification of Parkinson's patients.
    Gualerzi A; Picciolini S; Carlomagno C; Terenzi F; Ramat S; Sorbi S; Bedoni M
    Nanomedicine; 2019 Nov; 22():102097. PubMed ID: 31648040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome.
    Hrustincova A; Krejcik Z; Kundrat D; Szikszai K; Belickova M; Pecherkova P; Klema J; Vesela J; Hruba M; Cermak J; Hrdinova T; Krijt M; Valka J; Jonasova A; Merkerova MD
    Cells; 2020 Mar; 9(4):. PubMed ID: 32224889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.
    Li N; Pan X; Zhang J; Ma A; Yang S; Ma J; Xie A
    Neurol Sci; 2017 May; 38(5):761-767. PubMed ID: 28181066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNome detection analysis reveals 537 miRNAS in plasma, 625 in extracellular vesicles and a discriminant plasma signature of 19 miRNAs in children with retinoblastoma from which 14 are also detected in corresponding primary tumors.
    Castro-Magdonel BE; Orjuela M; Alvarez-Suarez DE; Camacho J; Cabrera-Muñoz L; Sadowinski-Pine S; Medina-Sanson A; Lara-Molina C; García-Vega D; Vázquez Y; Durán-Figueroa N; Orozco-Romero MJ; Hernández-Ángeles A; Ponce-Castañeda MV
    PLoS One; 2020; 15(4):e0231394. PubMed ID: 32287312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples.
    Chen L; Yang J; Lü J; Cao S; Zhao Q; Yu Z
    Brain Behav; 2018 Apr; 8(4):e00941. PubMed ID: 29670823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.
    Mercadal M; Herrero C; López-Rodrigo O; Castells M; de la Fuente A; Vigués F; Bassas L; Larriba S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin-conjugated magnetic nanoparticles for the isolation of brain-derived blood exosomal MicroRNAs: A novel approach for Parkinson's disease diagnosis.
    Jang YO; Roh Y; Shin W; Jo S; Koo B; Liu H; Kim MG; Lee HJ; Qiao Z; Lee EY; Lee M; Lee J; Lee EJ; Shin Y
    Anal Chim Acta; 2024 Jun; 1306():342623. PubMed ID: 38692796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.